Global Hospital-Acquired Infection Control Supply, Demand and Key Producers, 2023-2029

Page: 104

Published Date: 26 Aug 2023

Category: Service & Software

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Hospital-Acquired Infection Control market size is expected to reach $ 7101.9 million by 2029, rising at a market growth of 2.8% CAGR during the forecast period (2023-2029).

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

HAI is a term used to describe all infections that do not stem from the patient’s original diagnosis on admission.

HAIs are caused by bacteria, viruses or parasites that originate from the hospital environment, contaminated equipment, staff, or other patients. The most common types are urinary tract infections, chest infections, and surgical wound infections.

This report studies the global Hospital-Acquired Infection Control demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Hospital-Acquired Infection Control, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Hospital-Acquired Infection Control that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Hospital-Acquired Infection Control total market, 2018-2029, (USD Million)
Global Hospital-Acquired Infection Control total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Hospital-Acquired Infection Control total market, key domestic companies and share, (USD Million)
Global Hospital-Acquired Infection Control revenue by player and market share 2018-2023, (USD Million)
Global Hospital-Acquired Infection Control total market by Type, CAGR, 2018-2029, (USD Million)
Global Hospital-Acquired Infection Control total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global Hospital-Acquired Infection Control market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, Merck, Pfizer, 3M, Abbott, BD, Cepheid and Getinge Group, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Hospital-Acquired Infection Control market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Hospital-Acquired Infection Control Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Hospital-Acquired Infection Control Market, Segmentation by Type
Catheter-associated Urinary Tract Infections (CAUTIs)
Surgical Site Infections (SSIs)
Central Line-associated Bloodstream Infections (CLABSIs)
Respiratory Infections

Global Hospital-Acquired Infection Control Market, Segmentation by Application
Hospitals and ICUs
Outpatient Care Centers
Long-term Care Facilities (LTCFs)

Companies Profiled:
GSK
Merck
Pfizer
3M
Abbott
BD
Cepheid
Getinge Group

Key Questions Answered
1. How big is the global Hospital-Acquired Infection Control market?
2. What is the demand of the global Hospital-Acquired Infection Control market?
3. What is the year over year growth of the global Hospital-Acquired Infection Control market?
4. What is the total value of the global Hospital-Acquired Infection Control market?
5. Who are the major players in the global Hospital-Acquired Infection Control market?

Table of Contents

1 Supply Summary
    1.1 Hospital-Acquired Infection Control Introduction
    1.2 World Hospital-Acquired Infection Control Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Hospital-Acquired Infection Control Total Market by Region (by Headquarter Location)
        1.3.1 World Hospital-Acquired Infection Control Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Hospital-Acquired Infection Control Market Size (2018-2029)
        1.3.3 China Hospital-Acquired Infection Control Market Size (2018-2029)
        1.3.4 Europe Hospital-Acquired Infection Control Market Size (2018-2029)
        1.3.5 Japan Hospital-Acquired Infection Control Market Size (2018-2029)
        1.3.6 South Korea Hospital-Acquired Infection Control Market Size (2018-2029)
        1.3.7 ASEAN Hospital-Acquired Infection Control Market Size (2018-2029)
        1.3.8 India Hospital-Acquired Infection Control Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Hospital-Acquired Infection Control Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Hospital-Acquired Infection Control Major Market Trends

2 Demand Summary
    2.1 World Hospital-Acquired Infection Control Consumption Value (2018-2029)
    2.2 World Hospital-Acquired Infection Control Consumption Value by Region
        2.2.1 World Hospital-Acquired Infection Control Consumption Value by Region (2018-2023)
        2.2.2 World Hospital-Acquired Infection Control Consumption Value Forecast by Region (2024-2029)
    2.3 United States Hospital-Acquired Infection Control Consumption Value (2018-2029)
    2.4 China Hospital-Acquired Infection Control Consumption Value (2018-2029)
    2.5 Europe Hospital-Acquired Infection Control Consumption Value (2018-2029)
    2.6 Japan Hospital-Acquired Infection Control Consumption Value (2018-2029)
    2.7 South Korea Hospital-Acquired Infection Control Consumption Value (2018-2029)
    2.8 ASEAN Hospital-Acquired Infection Control Consumption Value (2018-2029)
    2.9 India Hospital-Acquired Infection Control Consumption Value (2018-2029)

3 World Hospital-Acquired Infection Control Companies Competitive Analysis
    3.1 World Hospital-Acquired Infection Control Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Hospital-Acquired Infection Control Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Hospital-Acquired Infection Control in 2022
        3.2.3 Global Concentration Ratios (CR8) for Hospital-Acquired Infection Control in 2022
    3.3 Hospital-Acquired Infection Control Company Evaluation Quadrant
    3.4 Hospital-Acquired Infection Control Market: Overall Company Footprint Analysis
        3.4.1 Hospital-Acquired Infection Control Market: Region Footprint
        3.4.2 Hospital-Acquired Infection Control Market: Company Product Type Footprint
        3.4.3 Hospital-Acquired Infection Control Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Hospital-Acquired Infection Control Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Hospital-Acquired Infection Control Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Hospital-Acquired Infection Control Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Hospital-Acquired Infection Control Consumption Value Comparison
        4.2.1 United States VS China: Hospital-Acquired Infection Control Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Hospital-Acquired Infection Control Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Hospital-Acquired Infection Control Companies and Market Share, 2018-2023
        4.3.1 United States Based Hospital-Acquired Infection Control Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Hospital-Acquired Infection Control Revenue, (2018-2023)
    4.4 China Based Companies Hospital-Acquired Infection Control Revenue and Market Share, 2018-2023
        4.4.1 China Based Hospital-Acquired Infection Control Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Hospital-Acquired Infection Control Revenue, (2018-2023)
    4.5 Rest of World Based Hospital-Acquired Infection Control Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Hospital-Acquired Infection Control Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Hospital-Acquired Infection Control Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Hospital-Acquired Infection Control Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Catheter-associated Urinary Tract Infections (CAUTIs)
        5.2.2 Surgical Site Infections (SSIs)
        5.2.3 Central Line-associated Bloodstream Infections (CLABSIs)
        5.2.4 Respiratory Infections
    5.3 Market Segment by Type
        5.3.1 World Hospital-Acquired Infection Control Market Size by Type (2018-2023)
        5.3.2 World Hospital-Acquired Infection Control Market Size by Type (2024-2029)
        5.3.3 World Hospital-Acquired Infection Control Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Hospital-Acquired Infection Control Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospitals and ICUs
        6.2.2 Outpatient Care Centers
        6.2.3 Long-term Care Facilities (LTCFs)
    6.3 Market Segment by Application
        6.3.1 World Hospital-Acquired Infection Control Market Size by Application (2018-2023)
        6.3.2 World Hospital-Acquired Infection Control Market Size by Application (2024-2029)
        6.3.3 World Hospital-Acquired Infection Control Market Size by Application (2018-2029)

7 Company Profiles
    7.1 GSK
        7.1.1 GSK Details
        7.1.2 GSK Major Business
        7.1.3 GSK Hospital-Acquired Infection Control Product and Services
        7.1.4 GSK Hospital-Acquired Infection Control Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 GSK Recent Developments/Updates
        7.1.6 GSK Competitive Strengths & Weaknesses
    7.2 Merck
        7.2.1 Merck Details
        7.2.2 Merck Major Business
        7.2.3 Merck Hospital-Acquired Infection Control Product and Services
        7.2.4 Merck Hospital-Acquired Infection Control Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Merck Recent Developments/Updates
        7.2.6 Merck Competitive Strengths & Weaknesses
    7.3 Pfizer
        7.3.1 Pfizer Details
        7.3.2 Pfizer Major Business
        7.3.3 Pfizer Hospital-Acquired Infection Control Product and Services
        7.3.4 Pfizer Hospital-Acquired Infection Control Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Pfizer Recent Developments/Updates
        7.3.6 Pfizer Competitive Strengths & Weaknesses
    7.4 3M
        7.4.1 3M Details
        7.4.2 3M Major Business
        7.4.3 3M Hospital-Acquired Infection Control Product and Services
        7.4.4 3M Hospital-Acquired Infection Control Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 3M Recent Developments/Updates
        7.4.6 3M Competitive Strengths & Weaknesses
    7.5 Abbott
        7.5.1 Abbott Details
        7.5.2 Abbott Major Business
        7.5.3 Abbott Hospital-Acquired Infection Control Product and Services
        7.5.4 Abbott Hospital-Acquired Infection Control Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Abbott Recent Developments/Updates
        7.5.6 Abbott Competitive Strengths & Weaknesses
    7.6 BD
        7.6.1 BD Details
        7.6.2 BD Major Business
        7.6.3 BD Hospital-Acquired Infection Control Product and Services
        7.6.4 BD Hospital-Acquired Infection Control Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 BD Recent Developments/Updates
        7.6.6 BD Competitive Strengths & Weaknesses
    7.7 Cepheid
        7.7.1 Cepheid Details
        7.7.2 Cepheid Major Business
        7.7.3 Cepheid Hospital-Acquired Infection Control Product and Services
        7.7.4 Cepheid Hospital-Acquired Infection Control Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Cepheid Recent Developments/Updates
        7.7.6 Cepheid Competitive Strengths & Weaknesses
    7.8 Getinge Group
        7.8.1 Getinge Group Details
        7.8.2 Getinge Group Major Business
        7.8.3 Getinge Group Hospital-Acquired Infection Control Product and Services
        7.8.4 Getinge Group Hospital-Acquired Infection Control Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Getinge Group Recent Developments/Updates
        7.8.6 Getinge Group Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Hospital-Acquired Infection Control Industry Chain
    8.2 Hospital-Acquired Infection Control Upstream Analysis
    8.3 Hospital-Acquired Infection Control Midstream Analysis
    8.4 Hospital-Acquired Infection Control Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Hospital-Acquired Infection Control Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Hospital-Acquired Infection Control Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Hospital-Acquired Infection Control Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Hospital-Acquired Infection Control Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Hospital-Acquired Infection Control Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Hospital-Acquired Infection Control Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Hospital-Acquired Infection Control Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Hospital-Acquired Infection Control Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Hospital-Acquired Infection Control Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Hospital-Acquired Infection Control Players in 2022
    Table 12. World Hospital-Acquired Infection Control Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Hospital-Acquired Infection Control Company Evaluation Quadrant
    Table 14. Head Office of Key Hospital-Acquired Infection Control Player
    Table 15. Hospital-Acquired Infection Control Market: Company Product Type Footprint
    Table 16. Hospital-Acquired Infection Control Market: Company Product Application Footprint
    Table 17. Hospital-Acquired Infection Control Mergers & Acquisitions Activity
    Table 18. United States VS China Hospital-Acquired Infection Control Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Hospital-Acquired Infection Control Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Hospital-Acquired Infection Control Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Hospital-Acquired Infection Control Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Hospital-Acquired Infection Control Revenue Market Share (2018-2023)
    Table 23. China Based Hospital-Acquired Infection Control Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Hospital-Acquired Infection Control Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Hospital-Acquired Infection Control Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Hospital-Acquired Infection Control Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Hospital-Acquired Infection Control Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Hospital-Acquired Infection Control Revenue Market Share (2018-2023)
    Table 29. World Hospital-Acquired Infection Control Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Hospital-Acquired Infection Control Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Hospital-Acquired Infection Control Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Hospital-Acquired Infection Control Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Hospital-Acquired Infection Control Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Hospital-Acquired Infection Control Market Size by Application (2024-2029) & (USD Million)
    Table 35. GSK Basic Information, Area Served and Competitors
    Table 36. GSK Major Business
    Table 37. GSK Hospital-Acquired Infection Control Product and Services
    Table 38. GSK Hospital-Acquired Infection Control Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. GSK Recent Developments/Updates
    Table 40. GSK Competitive Strengths & Weaknesses
    Table 41. Merck Basic Information, Area Served and Competitors
    Table 42. Merck Major Business
    Table 43. Merck Hospital-Acquired Infection Control Product and Services
    Table 44. Merck Hospital-Acquired Infection Control Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Merck Recent Developments/Updates
    Table 46. Merck Competitive Strengths & Weaknesses
    Table 47. Pfizer Basic Information, Area Served and Competitors
    Table 48. Pfizer Major Business
    Table 49. Pfizer Hospital-Acquired Infection Control Product and Services
    Table 50. Pfizer Hospital-Acquired Infection Control Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Pfizer Recent Developments/Updates
    Table 52. Pfizer Competitive Strengths & Weaknesses
    Table 53. 3M Basic Information, Area Served and Competitors
    Table 54. 3M Major Business
    Table 55. 3M Hospital-Acquired Infection Control Product and Services
    Table 56. 3M Hospital-Acquired Infection Control Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. 3M Recent Developments/Updates
    Table 58. 3M Competitive Strengths & Weaknesses
    Table 59. Abbott Basic Information, Area Served and Competitors
    Table 60. Abbott Major Business
    Table 61. Abbott Hospital-Acquired Infection Control Product and Services
    Table 62. Abbott Hospital-Acquired Infection Control Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Abbott Recent Developments/Updates
    Table 64. Abbott Competitive Strengths & Weaknesses
    Table 65. BD Basic Information, Area Served and Competitors
    Table 66. BD Major Business
    Table 67. BD Hospital-Acquired Infection Control Product and Services
    Table 68. BD Hospital-Acquired Infection Control Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. BD Recent Developments/Updates
    Table 70. BD Competitive Strengths & Weaknesses
    Table 71. Cepheid Basic Information, Area Served and Competitors
    Table 72. Cepheid Major Business
    Table 73. Cepheid Hospital-Acquired Infection Control Product and Services
    Table 74. Cepheid Hospital-Acquired Infection Control Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Cepheid Recent Developments/Updates
    Table 76. Getinge Group Basic Information, Area Served and Competitors
    Table 77. Getinge Group Major Business
    Table 78. Getinge Group Hospital-Acquired Infection Control Product and Services
    Table 79. Getinge Group Hospital-Acquired Infection Control Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 80. Global Key Players of Hospital-Acquired Infection Control Upstream (Raw Materials)
    Table 81. Hospital-Acquired Infection Control Typical Customers
List of Figure
    Figure 1. Hospital-Acquired Infection Control Picture
    Figure 2. World Hospital-Acquired Infection Control Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Hospital-Acquired Infection Control Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Hospital-Acquired Infection Control Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Hospital-Acquired Infection Control Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Hospital-Acquired Infection Control Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Hospital-Acquired Infection Control Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Hospital-Acquired Infection Control Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Hospital-Acquired Infection Control Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Hospital-Acquired Infection Control Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Hospital-Acquired Infection Control Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Hospital-Acquired Infection Control Revenue (2018-2029) & (USD Million)
    Figure 13. Hospital-Acquired Infection Control Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Hospital-Acquired Infection Control Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Hospital-Acquired Infection Control Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Hospital-Acquired Infection Control Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Hospital-Acquired Infection Control Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Hospital-Acquired Infection Control Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Hospital-Acquired Infection Control Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Hospital-Acquired Infection Control Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Hospital-Acquired Infection Control Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Hospital-Acquired Infection Control Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Hospital-Acquired Infection Control by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Hospital-Acquired Infection Control Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Hospital-Acquired Infection Control Markets in 2022
    Figure 27. United States VS China: Hospital-Acquired Infection Control Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Hospital-Acquired Infection Control Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Hospital-Acquired Infection Control Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Hospital-Acquired Infection Control Market Size Market Share by Type in 2022
    Figure 31. Catheter-associated Urinary Tract Infections (CAUTIs)
    Figure 32. Surgical Site Infections (SSIs)
    Figure 33. Central Line-associated Bloodstream Infections (CLABSIs)
    Figure 34. Respiratory Infections
    Figure 35. World Hospital-Acquired Infection Control Market Size Market Share by Type (2018-2029)
    Figure 36. World Hospital-Acquired Infection Control Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 37. World Hospital-Acquired Infection Control Market Size Market Share by Application in 2022
    Figure 38. Hospitals and ICUs
    Figure 39. Outpatient Care Centers
    Figure 40. Long-term Care Facilities (LTCFs)
    Figure 41. Hospital-Acquired Infection Control Industrial Chain
    Figure 42. Methodology
    Figure 43. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

GSK
Merck
Pfizer
3M
Abbott
BD
Cepheid
Getinge Group

Related Reports

Global Hospital-Acquired Infection Control Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Hospital-Acquired Infection Control Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 26 Aug 2023

date Service & Software

According to our (Global Info Research) latest study, the global Hospital-Acquired Infection Control market size was valued at USD 5867.2 million in 2022 and is forecast to a readjusted size of USD 7101.9 million by 2029 with a CAGR of 2.8% during review period.

Global Hospital-Acquired Infection Control Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Hospital-Acquired Infection Control Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Service & Software

According to our (Global Info Research) latest study, the global Hospital-Acquired Infection Control market size was valued at USD 5867.2 million in 2023 and is forecast to a readjusted size of USD 7101.9 million by 2030 with a CAGR of 2.8% during review period.

Global Hospital-Acquired Infection Control Supply, Demand and Key Producers, 2024-2030

Global Hospital-Acquired Infection Control Supply, Demand and Key Producers, 2024-2030

date 08 Feb 2024

date Service & Software

The global Hospital-Acquired Infection Control market size is expected to reach $ 7101.9 million by 2030, rising at a market growth of 2.8% CAGR during the forecast period (2024-2030).

Product Tags

Hospital-Acquired Infection Control

Hospital Acquired Infection Control

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>